Ratings by BofA Securities (Allen Lutz)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/23/2022 | Babylon Holdings | BBLN | New Coverage | Neutral (N/A) |
1.17 (1.03) |
-11.97% | Details | |
| 5/18/2022 | Doximity Inc | DOCS | Maintain | Neutral (N/A) |
|
Details | ||
| 4/14/2022 | HealthEquity, Inc | HQY | Maintain | Buy (N/A) |
|
Details | ||
| 4/4/2022 | Doximity Inc | DOCS | New Coverage | Neutral (N/A) |
52.79 (37.98) |
-28.05% | Details | |
| 12/7/2021 | HealthEquity, Inc | HQY | Maintain | Buy (N/A) |
|
Details | ||
| 10/28/2021 | Teladoc | TDOC | Maintain | Neutral (N/A) |
|
Details | ||
| 10/22/2021 | Teladoc | TDOC | Maintain | Neutral (N/A) |
|
Details | ||
| 10/6/2021 | HealthEquity, Inc | HQY | Maintain | Buy (N/A) |
|
Details | ||
| 9/9/2021 | HealthEquity, Inc | HQY | Maintain | Buy (N/A) |
|
Details | ||
| 7/28/2021 | Teladoc | TDOC | Maintain | Neutral (N/A) |
|
Details | ||
| 7/21/2021 | Teladoc | TDOC | Maintain | Neutral (N/A) |
|
Details | ||
| 3/18/2021 | Teladoc | TDOC | Maintain | Neutral (N/A) |
|
Details | ||
| 2/25/2021 | Teladoc | TDOC | Maintain | Neutral (N/A) |
|
Details | ||
| 1/24/2020 | Teladoc | TDOC | Maintain | Neutral (N/A) |
|
Details | ||
| 1/9/2020 | Teladoc | TDOC | Downgrade | Neutral (Buy) |
86.22 (35.08) |
-59.31% | Details | |
| 11/8/2019 | HealthEquity, Inc | HQY | Maintain | Buy (N/A) |
|
Details | ||
| 10/31/2019 | Teladoc | TDOC | Maintain | Buy (N/A) |
|
Details | ||
| 9/4/2019 | HealthEquity, Inc | HQY | Maintain | Buy (N/A) |
|
Details | ||
| 7/19/2019 | HealthEquity, Inc | HQY | Upgrade | Buy (Neutral) |
75.36 (65.12) |
-13.59% | Details | |
| 6/5/2019 | HealthEquity, Inc | HQY | Maintain | Neutral (N/A) |
|
Details | ||
| 3/19/2019 | HealthEquity, Inc | HQY | Maintain | Neutral (N/A) |
|
Details | ||
| 3/1/2019 | HealthEquity, Inc | HQY | Maintain | Neutral (N/A) |
|
Details | ||
| 9/6/2018 | HealthEquity, Inc | HQY | Downgrade | Neutral (Buy) |
94.47 (75.36) |
-20.23% | Details |
